273 related articles for article (PubMed ID: 17413764)
1. The efficiency of anti-activated factor X and anti-activated factor II anticoagulants.
Stief TW
Blood Coagul Fibrinolysis; 2007 Apr; 18(3):265-9. PubMed ID: 17413764
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of extrinsic hemostasis activation by low-molecular-weight heparin.
Stief TW
Blood Coagul Fibrinolysis; 2006 Nov; 17(8):633-7. PubMed ID: 17102649
[TBL] [Abstract][Full Text] [Related]
3. Determination of the anti-F10a or anti-F2a generation action of rivaroxaban or dabigatran.
Stief TW
Blood Coagul Fibrinolysis; 2012 Oct; 23(7):619-21. PubMed ID: 22821003
[TBL] [Abstract][Full Text] [Related]
4. Influence of coagulation factors on extrinsic thrombin generation.
Stief TW; Wieczerzak A; Renz H
Blood Coagul Fibrinolysis; 2007 Mar; 18(2):105-12. PubMed ID: 17287625
[TBL] [Abstract][Full Text] [Related]
5. The intrinsic coagulation activity assay.
Stief TW; Otto S; Renz H
Blood Coagul Fibrinolysis; 2006 Jul; 17(5):369-78. PubMed ID: 16788313
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of thrombin generation in recalcified plasma.
Stief TW
Blood Coagul Fibrinolysis; 2007 Dec; 18(8):751-60. PubMed ID: 17982316
[TBL] [Abstract][Full Text] [Related]
7. The anticoagulant capacity of plasmatic unfractionated heparin decreases at 23 degrees C.
Stief TW
Blood Coagul Fibrinolysis; 2007 Mar; 18(2):209-12. PubMed ID: 17287642
[TBL] [Abstract][Full Text] [Related]
8. The extrinsic coagulation activity assay.
Stief TW; Wieczerzak A; Renz H
Clin Appl Thromb Hemost; 2008 Jul; 14(3):303-18. PubMed ID: 18586682
[TBL] [Abstract][Full Text] [Related]
9. Specific determination of plasmatic thrombin activity.
Stief TW
Clin Appl Thromb Hemost; 2006 Jul; 12(3):324-9. PubMed ID: 16959686
[TBL] [Abstract][Full Text] [Related]
10. Influence of the surface on thrombin generation.
Stief TW
Int J Lab Hematol; 2008 Aug; 30(4):269-77. PubMed ID: 18665823
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of factor IIa inhibitors on the endogenous thrombin potential.
Beilfuss A; Grandoch M; Wenzel F; Hohlfeld T; Schrör K; Weber AA
Ther Drug Monit; 2008 Dec; 30(6):740-3. PubMed ID: 18824953
[TBL] [Abstract][Full Text] [Related]
12. Kallikrein activates prothrombin.
Stief TW
Clin Appl Thromb Hemost; 2008 Jan; 14(1):97-8. PubMed ID: 18160576
[TBL] [Abstract][Full Text] [Related]
13. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
14. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
[TBL] [Abstract][Full Text] [Related]
15. Xa inhibition and coagulation activity--the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals.
Oldgren J; Johnston N; Siegbahn A
Am Heart J; 2008 Mar; 155(3):493.e1-8. PubMed ID: 18294482
[TBL] [Abstract][Full Text] [Related]
16. Heparin chain-length dependence of factor Xa inhibition by antithrombin in plasma.
Rezaie AR
Thromb Res; 2007; 119(4):481-8. PubMed ID: 16515805
[TBL] [Abstract][Full Text] [Related]
17. Thrombin generation by exposure of blood to endotoxin: a simple model to study disseminated intravascular coagulation.
Stief TW
Clin Appl Thromb Hemost; 2006 Apr; 12(2):137-61. PubMed ID: 16708116
[TBL] [Abstract][Full Text] [Related]
18. The recalcified coagulation activity.
Stief TW
Clin Appl Thromb Hemost; 2008 Oct; 14(4):447-53. PubMed ID: 18160574
[TBL] [Abstract][Full Text] [Related]
19. Differential coagulation inhibitory effect of fondaparinux, enoxaparin and unfractionated heparin in cell models of thrombin generation.
Ben-Hadj-Khalifa S; Hézard N; Almawi WY; Remy MG; Florent B; Mahjoub T; Nguyen P
Blood Coagul Fibrinolysis; 2011 Jul; 22(5):369-73. PubMed ID: 21577096
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of thrombin in plasma by heparin or arginine.
Stief TW
Clin Appl Thromb Hemost; 2007 Apr; 13(2):146-53. PubMed ID: 17456623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
